PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27374084-5	2016	However, sunitinib treatment of Ela-myc mice with either early or advanced tumor progression had no impact on either survival or tumor burden.	Sunitinib	9-18	apelin receptor early endogenous ligand	Mus musculus	32-35	
27374084-7	2016	In stark contrast, in vitro sunitinib treatment of Ela-myc- derived cell lines showed high sensitivity to the drug, with increased apoptosis and reduced proliferation.	Sunitinib	28-37	apelin receptor early endogenous ligand	Mus musculus	51-54